Currently submitted to: JMIR Public Health and Surveillance
Date Submitted: Feb 2, 2026
Open Peer Review Period: Feb 2, 2026 - Mar 30, 2026
(closed for review but you can still tweet)
NOTE: This is an unreviewed Preprint
Warning: This is a unreviewed preprint (What is a preprint?). Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn (a note "no longer under consideration" will appear above).
Peer review me: Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period (in this case, a "Peer Review Me" button to sign up as reviewer is displayed above). All preprints currently open for review are listed here. Outside of the formal open peer-review period we encourage you to tweet about the preprint.
Citation: Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author).
Final version: If our system detects a final peer-reviewed "version of record" (VoR) published in any journal, a link to that VoR will appear below. Readers are then encourage to cite the VoR instead of this preprint.
Settings: If you are the author, you can login and change the preprint display settings, but the preprint URL/DOI is supposed to be stable and citable, so it should not be removed once posted.
Submit: To post your own preprint, simply submit to any JMIR journal, and choose the appropriate settings to expose your submitted version as preprint.
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
The power of Engaging Civil Society Organization in the screening and management of chronic diseases: Evidence from Tunisia
ABSTRACT
Background:
Type 2 diabetes (T2D) and high blood pressure (HBP) are major public health challenges worldwide, leading to serious complications, disability, and mortality. In Tunisia, the contribution of civil society organizations (CSOs) to the prevention and management of these non-communicable diseases (NCDs) remains limited.
Objective:
This study aimed to assess the epidemiological situation of T2D and HBP in North-East Tunisia and to examine the added value of CSO involvement in research and advocacy.
Methods:
A community-based participatory research approach was implemented, coordinated by the Science Shop at the Institut Pasteur de Tunis, in partnership with the Regional Association of Diabetics in Zaghouan. Epidemiological data were collected from 420 volunteer participants to estimate the prevalence of T2D and HBP in northeastern Tunisia (Zaghouan region) and to identify associated risk factors. In parallel, members of civil society organizations (CSOs) actively contributed to identifying community priorities, awareness gaps, and barriers to effective disease management
Results:
Findings revealed a concerning increase in the prevalence of T2D and HBP in the region, emphasizing the urgent need for targeted interventions. The engagement of CSOs strengthened the relevance and impact of research, improved community participation, and facilitated dialogue with policymakers.
Conclusions:
In conclusion, this study underscores the pivotal role of CSO–research partnerships in bridging science and society, promoting evidence-based health actions, and enhancing policy responses to NCDs in Tunisia
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.